Xyotax Retains Fast Track Status For Certain Female Lung Cancer Patients
Trials of Xyotax in women with lung cancer who have normal estrogen levels are landmark studies using estrogen as a biomarker, CTI says.
Trials of Xyotax in women with lung cancer who have normal estrogen levels are landmark studies using estrogen as a biomarker, CTI says.